<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">In a Ces1c-knockout mouse model of SARS-CoV infection, prophylactic and therapeutic remdesivir treatment resulted in lower lung viral titers, and if therapy was administered 1 day post-infection (which is before peak viral replication), it was associated with greater pulmonary function, compared to controls [
 <xref rid="bb0055" ref-type="bibr">11</xref>]. However, there were no differences in disease pathology or survival if treatment was administered 2 days post-infection.
</p>
